C
Overview
Cook Group manufactures medical devices focused on minimally invasive procedures. Its Cook Medical division develops and produces a broad portfolio—over 16,000 products—across cardiology, urology, gastroenterology, endoscopy, and vascular care. The company sells to hospitals and clinics worldwide, operating a B2B model in about 135 countries, with a European footprint centered in Ireland. As a family-owned business led by Carl Cook, it aims to support clinicians with reliable technologies and clinical support to expand alternatives to open surgery.
Work here?Claim your company
Simplify's take
What believers are saying
- Cook updated Europe locations on November 7, 2026, showing Limerick and Bjaeverskov still expanding.
- The company still employs more than 950 in Limerick and over 800 in Denmark.
- FDA-cleared product sales continue, including Zenith ZBIS commercial availability in the United States.
What critics are saying
- FDA classified Cook’s sizing-catheter recall Class I on May 5, 2026.
- More than 6,400 blood-clot-filter cases still pending in October 2026 threaten cash and reputation.
- A multibillion-dollar filter verdict forces asset sales and ends family control.
What makes Cook Group unique
- Cook’s 1969 Denmark base and Limerick headquarters anchor a deep European manufacturing network.
- Its 16,000-product portfolio spans cardiology, urology, and gastroenterology across 135 countries.
- Physician-driven R&D remains central, with Limerick’s Innovation Centre built for collaborative development.
Help us improve and share your feedback! Did you find this helpful?